RESEARCH TRIANGLE PARK, N.C. – Dr. Kenneth J. Rothman, premier research epidemiologist and author of two seminal textbooks on epidemiology, joined RTI Health Solutions (RTI-HS) on July 1, 2005, as vice president of Epidemiology Research.

Rothman’s addition strengthens RTI-HS’ ongoing initiatives in pharmacoepidemiology and therapeutic risk management. In his new role, Rothman will provide leadership in the application of advanced methods in nonexperimental research to address a variety of client issues, particularly in the area of drug safety and risk assessment.
" We are extremely pleased to have Ken join our growing organization,” said Dr. Allen Mangel, vice president of RTI Health Solutions “He will provide us with an enhanced capability to serve our clients throughout the pharmaceutical industry, putting us at the forefront of epidemiologic methodology. Our strong team of epidemiology researchers is enthusiastic about the opportunity to work with Ken. The combination of Dr. Rothman and Dr. Elizabeth Andrews, our vice president of Risk Management, will create an incredibly sophisticated risk management team.”
Rothman was co-founder of Epidemiology Resources, Inc., the precursor of the epidemiology group at Ingenix. He was the founding editor of Epidemiology and has authored more than 200 scholarly publications, including the widely-used textbooks "Modern Epidemiology" and “Epidemiology – An Introduction.”

Dr. Rothman also holds an appointment as Professor of Epidemiology and Professor of Medicine at Boston University. He also served as President of the Society for Epidemiologic Research and is an Honorary Fellow of the American College of Epidemiology. He received the Will Solimene Award for Excellence from the American Medical Writers Association and the Abraham Lilienfeld Teaching Award from the American Public Health Association.

He currently serves on the Board of Directors of the International Society of Pharmacoepidemiology (ISPE). In addition to his contributions to epidemiology methods and teaching, his research has covered multiple therapeutic areas, such as cancer, cardiovascular disease, neurologic disease, birth defects, environmental exposures and drug epidemiology.

“I am delighted at the opportunity to join the team of distinguished scientists at RTI Health Solutions and contribute to their outstanding reputation for research and consulting in epidemiology and risk management,” Rothman said.